These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20080926)

  • 61. Effect of ecstasy use on neuropsychological function: a study in Hong Kong.
    Yip JT; Lee TM
    Psychopharmacology (Berl); 2005 May; 179(3):620-8. PubMed ID: 15650845
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Semantic fluency in aphasia: clustering and switching in the course of 1 minute.
    Bose A; Wood R; Kiran S
    Int J Lang Commun Disord; 2017 May; 52(3):334-345. PubMed ID: 27767243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for significant polydrug use among ecstasy-using college students.
    Wish ED; Fitzelle DB; O'Grady KE; Hsu MH; Arria AM
    J Am Coll Health; 2006; 55(2):99-104. PubMed ID: 17017306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
    Cowan RL; Joers JM; Dietrich MS
    Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ERP evidence suggests executive dysfunction in ecstasy polydrug users.
    Roberts CA; Fairclough SH; Fisk JE; Tames F; Montgomery C
    Psychopharmacology (Berl); 2013 Aug; 228(3):375-88. PubMed ID: 23532375
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Getting into ecstasy: comparing moderate and heavy young adult users.
    Sterk CE; Theall KP; Elifson KW
    J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meta-analysis of executive functioning in ecstasy/polydrug users.
    Roberts CA; Jones A; Montgomery C
    Psychol Med; 2016 Jun; 46(8):1581-96. PubMed ID: 26966023
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects.
    Verbaten MN
    Curr Drug Abuse Rev; 2010 Sep; 3(3):129-38. PubMed ID: 21054259
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.
    Yubero-Lahoz S; Kuypers KP; Ramaekers JG; Langohr K; Farré M; de la Torre R
    Psychopharmacology (Berl); 2015 Jun; 232(11):1921-9. PubMed ID: 25524139
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Associations between genetic risk, functional brain network organization and neuroticism.
    Servaas MN; Geerligs L; Bastiaansen JA; Renken RJ; Marsman JC; Nolte IM; Ormel J; Aleman A; Riese H
    Brain Imaging Behav; 2017 Dec; 11(6):1581-1591. PubMed ID: 27743374
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sleep impairment in ecstasy/polydrug and cannabis-only users.
    Fisk JE; Montgomery C
    Am J Addict; 2009; 18(5):430-7. PubMed ID: 19874164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption.
    Wolff K; Tsapakis EM; Pariante CM; Kerwin RW; Forsling ML; Aitchison KJ
    J Psychopharmacol; 2012 Mar; 26(3):419-28. PubMed ID: 21969106
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.
    Schilt T; Koeter MW; Smal JP; Gouwetor MN; van den Brink W; Schmand B
    Psychopharmacology (Berl); 2010 Jan; 207(4):583-91. PubMed ID: 19823808
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ecstasy exposure & gender: examining components of verbal memory functioning.
    Price JS; Shear P; Lisdahl KM
    PLoS One; 2014; 9(12):e115645. PubMed ID: 25545890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential effects of ecstasy on short-term and working memory: a meta-analysis.
    Nulsen CE; Fox AM; Hammond GR
    Neuropsychol Rev; 2010 Mar; 20(1):21-32. PubMed ID: 20157852
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
    Scott RM; Hides L; Allen JS; Burke R; Lubman DI
    Psychopharmacology (Berl); 2010 Mar; 209(1):25-36. PubMed ID: 20101393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.
    Freeman TP; Morgan CJ; Vaughn-Jones J; Hussain N; Karimi K; Curran HV
    Addiction; 2012 Apr; 107(4):792-800. PubMed ID: 22257011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of study characteristics with estimates of effect size in studies of ecstasy use.
    Taylor EM; Greene NM; Morgan CJ; Munafò MR
    J Psychopharmacol; 2011 Nov; 25(11):1573-7. PubMed ID: 21937685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Qualitative analysis of verbal fluency output: review and comparison of several scoring methods.
    Abwender DA; Swan JG; Bowerman JT; Connolly SW
    Assessment; 2001 Sep; 8(3):323-38. PubMed ID: 11575625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.